ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 30

Gene Expression Profiling Analysis Of Human B-Cell Subsets In Health and Systemic Lupus Erythematosus

Chungwen Wei1, Edward Ramos2, Norm Allaire3, Suzanne Szak3, Susan Kalled3, Ann Ranger3 and Ignacio Sanz1, 1Rheumatology, Emory University, Atlanta, GA, 2Biology, Emory University, Atlanta, GA, 3Biogen Idec Inc, Cambridge, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: B cells, Gene Expression and SLE

  • Tweet
  • Email
  • Print
Session Information

Title: B cell Function and Targeting in Systemic Lupus Erythematosus

Session Type: Abstract Submissions (ACR)

Background/Purpose: SLE is an autoimmune disease, which exhibits multiple B cell abnormalities including expanded populations of plasmablasts and DN memory cells as well as a contracted unswitched memory subset.  The transcriptional profiles that underlie these homeostatic changes are poorly understood. To remedy this knowledge gap and generate insight into the disease pathogenesis, we carried out transcriptome analysis of sorted B cell subsets. 

Methods: B cell subsets were flow sorted from 12 healthy controls (HC) and 13 SLE patients with low disease activity (SLEDAI<6):  naïve (IgD+CD27–), unswitched memory (IgD+CD27+), switched memory (IgD–CD27+), DN memory (IgD–CD27–) and plasmablasts (IgD–CD27++CD38++).  Total RNA was hybridized to Human Genome U133 Plus 2.0 GeneChip (Affymetrix).  The scans were subjected to quality control measures and the resulting CEL files normalized with Robust Multi-array Average (RMA).  All calculations and analyses were carried out using R/Bioconductor computational tools.  To identify differentially expressed genes (DEGs) between groups of samples, a two-way ANOVA model using Method of Moments was applied.  Gene that exhibited a FDR <0.05 and fold change >2 or <-2 were considered significantly different.

Results: Overall, there are fewer DEGs among the three memory B cell subsets than between naïve and each of the three memory subsets in both healthy subjects and SLE patients, suggesting that the gene expression program is quite similar among all the memory B cells in HC and SLE.  IL4R and IL21R are upregulated in naïve cells whereas IL6R is over-expressed in memory cells.  Also upregulated in naïve cells is TCL1A, which promotes Akt-mediated survival.  TACI is upregulated in the switched and unswitched memory subsets compared to naïve cells in HC and SLE, and is higher in SLE DN B cells compared to the same population in HC.  SLE DN cells had also higher levels of AICDA and FcRL4.  Overall, most DEGs differentials between the two cohorts were identified in the DN subset.  Within either cohort, thousands of DEGs were observed between plasmablasts and the other four B cell subsets.

Conclusion: The transcriptome of multiple B cell subsets was remarkably similar between HC and SLE patients with low disease activity suggesting that most differences in active disease may be due to extrinsic differences.  Our results are consistent with the important role of IL-4 and IL-21 as growth factors for naïve cells and the known activity of IL-6 in memory differentiation into plasma cells. Of great interest is the upregulation of TACI, AICDA and FcRL4 in DN B cells, a population expanded in SLE.  The implications for the potential germinal center origin and activation status of these cells, reported to represent exhausted cells in HIV infection, will be discussed.


Disclosure:

C. Wei,

Biogen Idec,

2;

E. Ramos,
None;

N. Allaire,

Biogen Idec,

1,

Biogen Idec,

3;

S. Szak,

Biogen Idec,

1,

Biogen Idec,

3;

S. Kalled,

Biogen Idec,

1,

Biogen Idec,

3;

A. Ranger,

Biogen Idec,

1,

Biogen Idec,

3;

I. Sanz,

Biogen Idec,

2,

Pfizer Inc,

9.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gene-expression-profiling-analysis-of-human-b-cell-subsets-in-health-and-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology